Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 5 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
5(100.0%)
5Total
N/A(5)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT06052930Not ApplicableCompleted

Immersive Virtual Reality for the Non-pharmacological Management of Parkinson's Disease

Role: lead

NCT05538455Not ApplicableCompleted

Investigating ProCare4Life Impact on Quality of Life of Elderly Subjects With Neurodegenerative Diseases

Role: collaborator

NCT04699617Not ApplicableCompleted

The Feasibility and Efficacy of an Immersive Virtual Reality Software in Parkinson's Disease Patients

Role: lead

NCT03891069Not ApplicableCompleted

Feasibility of the AHA Exergame System in Parkinson's Disease Patients

Role: lead

NCT03123601Not ApplicableCompleted

Feasibility of Risk Sign Displays to Prevent Falls, Dehydration and Pulmonary Aspiration in Nursing Homes

Role: lead

All 5 trials loaded